about
Motivations of children and their parents to participate in drug research: a systematic reviewThe Safety of Drug Therapy in ChildrenHow to improve the implementation of academic clinical pediatric trials involving drug therapy? A qualitative study of multiple stakeholdersAutomated detection of off-label drug useEvaluation of Off-label Prescribing at a Children's Rehabilitation Center.Pediatric fluoroquinolone prescription in South Korea before and after a regulatory intervention: A nationwide study, 2007-2015.Towards evidence-based dosing regimens in children on the basis of population pharmacokinetic pharmacodynamic modelling.Adverse drug reactions and off-label and unlicensed medicines in children: a nested case-control study of inpatients in a pediatric hospital.Off-label medicine use in pediatric inpatients: a prospective observational study at a tertiary care hospital in IndiaDosing in neonates: special considerations in physiology and trial design.Successful nilotinib treatment in a child with chronic myeloid leukemiaOff-label paediatric drug use in an Indonesian community setting.Detection of an endogenous urinary biomarker associated with CYP2D6 activity using global metabolomicsHearing the voices of children: self-reported information on children's experiences during research procedures: a study protocol.Awareness, knowledge and views of off-label prescribing in children: a systematic reviewNatural Language Processing for EHR-Based Pharmacovigilance: A Structured Review.Medication Repurposing in Pediatric Patients: Teaching Old Drugs New TricksDevelopment of a population pharmacokinetic model of prucalopride in children with functional constipation.Drug Utilization on Neonatal Wards: A Systematic Review of Observational Studies.Scaling clearance in paediatric pharmacokinetics: All models are wrong, which are useful?Microdosing and Other Phase 0 Clinical Trials: Facilitating Translation in Drug Development.Pharmacogenomics and adverse drug reactions in children.Ethical aspects of clinical research with minors.The Nordic prescription databases as a resource for pharmacoepidemiological research--a literature review.Use of off-label and unlicenced drugs in hospitalised paediatric patients: a systematic review.Ethics of drug research in the pediatric intensive care unit.Prediction of drug clearance in children.Paediatric off-label and unlicensed prescribing in primary care in Malta: Prospective observational drug utilisation study.Dosing antibiotics in neonates: review of the pharmacokinetic data.Lower Extremity Abscess Formation in Premature Infants due to Routine Infant Vaccinations.Safety profile of H1-antihistamines in pediatrics: an analysis based on data from VigiBase.Off-label prescribing for children with chronic diseases in Nigeria; findings and implications.Binge Drinking: Current Diagnostic and Therapeutic Issues.Pharmacological sedation management in the paediatric intensive care unit.Current needs in pediatric pharmacoepidemiology.Off-label use of antimicrobials in neonates in a tertiary children's hospital.Oral drug absorption in pediatrics: the intestinal wall, its developmental changes and current tools for predictions.Scalpels not hammers: The way forward for precision drug prescription.Retapamulin prescriptions and monitored off-label use.Intra-Target Microdosing (ITM): A Novel Drug Development Approach Aimed at Enabling Safer and Earlier Translation of Biological Insights Into Human Testing.
P2860
Q26753051-A595EA58-BE4D-4A87-8D6B-F7CD476F0C3AQ28079478-35F61862-C799-40AD-B804-BD55C486F4CEQ28533359-A8AAF7AB-1058-433C-8023-7384BE8ED965Q28539923-14040AF1-128F-456E-84A1-4EA7CE7ECFE2Q30300386-74450369-04BB-481D-A09B-873F2A4D4DFDQ33698908-721BF910-3C84-4F54-8777-0D63CCF2D2FCQ34393200-548BD46C-882A-4D2D-B8FE-1874EDBEEB95Q34509390-6AAB1C92-5A4B-4C36-AF65-2BC4746241D0Q34675114-C70A88CA-1010-4491-8322-B7FE82DB0B52Q34716879-AB773D54-3988-466F-A731-C005A22B2914Q35225342-3DCCE9F3-70E2-42ED-BD5E-D433B6CB20D4Q35605202-96D8C1AC-35FE-431C-BFA9-B6FE1F5DC27CQ35800807-4238FC1A-2377-4548-BD79-AAA253D28E93Q36178793-9A5E16D7-6B55-42BC-8352-A4DFF6CA6A6CQ36410064-D862A102-0C97-47C6-AAFA-B25DF47060F2Q36413039-5E2DAA65-C2B9-48A3-BB28-46ADDD3DD820Q36652800-31A9E941-3436-4D2B-980A-C86700E95B56Q37421978-2AFB9CC9-3B2F-40E1-A6DA-6DED2E561E91Q37631267-97FA18A0-8245-4E6B-9C7D-86F920EA4C32Q37695055-DC146E48-826C-46B2-B6CA-D6D94970949CQ37701128-9933EF85-927F-4C10-BEFC-5998AFC17957Q37719025-9479C282-33FC-4292-A459-7B83019C4E7CQ38052860-080723C8-F279-4946-B9F6-63621EC4EF97Q38109104-FE2E3C4C-AD09-45FB-9617-B94C7AE37EB0Q38260525-259EAF83-9326-40EE-957A-A62F35245785Q38263726-F2D5DDF3-FED0-487D-82BF-E04CEB44539DQ38365645-D74EFC84-B666-429A-89CE-B8CC605EFB61Q38593684-55061889-F7B4-41DF-A39E-B66A521A32ECQ38649419-4C001AB9-8274-4A07-B18B-824BDADB7E74Q38683197-98705848-7A39-4260-89B3-C0F71C1FE542Q38707417-5B7122AC-5AAC-41B7-95A2-BAE23FC2F541Q38719436-CBC120CB-DED6-470B-A0FD-52E50DB7A5D3Q38756813-BD8377DF-9209-4516-B5B0-8CD3BFF9C84BQ38829350-F0BF2912-A5BC-4320-A1B3-76ADAA0C5A15Q38903940-27F742CC-07DE-4C5A-AE3D-55A03D482714Q39013368-9ED68D8E-9E59-4EFD-BCAF-3A9365D04E37Q39038877-8AA81A30-C4DC-44B0-BFF9-6E1023A8ADBBQ39041485-5E7D5228-7DA5-4E71-9161-5583FA9B531DQ39174966-1D59C8F7-B3D7-4A88-891A-58B85A921B66Q39248701-1C90494B-C112-4668-84DE-C608DB3F8DB4
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Off-label drug use in pediatric patients.
@en
Off-label drug use in pediatric patients.
@nl
type
label
Off-label drug use in pediatric patients.
@en
Off-label drug use in pediatric patients.
@nl
prefLabel
Off-label drug use in pediatric patients.
@en
Off-label drug use in pediatric patients.
@nl
P2860
P356
P1476
Off-label drug use in pediatric patients.
@en
P2093
P2860
P304
P356
10.1038/CLPT.2012.26
P407
P577
2012-05-01T00:00:00Z